Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pediatrix Medical (MD) Net Margin (2016 - 2025)

Pediatrix Medical (MD) has disclosed Net Margin for 16 consecutive years, with 9.23% as the latest value for Q4 2025.

  • On a quarterly basis, Net Margin rose 360.0% to 9.23% in Q4 2025 year-over-year; TTM through Dec 2025 was 9.26%, a 1429.0% increase, with the full-year FY2025 number at 11.31%, changed N/A from a year prior.
  • Net Margin was 9.23% for Q4 2025 at Pediatrix Medical, down from 14.55% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 14.55% in Q3 2025 to a low of 30.34% in Q2 2024.
  • A 4-year average of 1.39% and a median of 1.28% in 2021 define the central range for Net Margin.
  • Peak YoY movement for Net Margin: skyrocketed 16451bps in 2021, then crashed -280bps in 2022.
  • Pediatrix Medical's Net Margin stood at 1.45% in 2021, then fell by -24bps to 1.1% in 2022, then surged by 412bps to 5.64% in 2024, then skyrocketed by 64bps to 9.23% in 2025.
  • Per Business Quant, the three most recent readings for MD's Net Margin are 9.23% (Q4 2025), 14.55% (Q3 2025), and 8.37% (Q2 2025).